Levofloxacin Tablet, Film Coated
Product Images NDC 65862-537

7 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 65862-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg (50 Tablet Bottle))

Package Label-principal Display Panel (250 mg (50 Tablet Bottle))
Label for Once-a-day Levofloxacin Tablets USP 250 mg, film-coated tablets for oral use. Contains 50 tablets. Distributed by Aurobindo Pharma USA, Inc., with manufacturing in India. Includes storage instructions, dosing note to see package insert, and pharmacist dispensing instructions.*
FDA Label Image

Package Label-principal Display Panel (250 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (250 mg Blister Carton (10 x 10 Unit-dose))
Packaging label for Levofloxacin Tablets USP 250 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates a once-a-day dosage with 100 unit-dose tablets (10 x 10). It includes pharmacist instructions, storage information, distributor details, and barcodes.*
FDA Label Image

Package Label-principal Display Panel (500 mg (50 Tablet Bottle))

Package Label-principal Display Panel (500 mg (50 Tablet Bottle))
Label for Once-a-day Levofloxacin Tablets USP 500 mg film-coated tablets by Aurobindo Pharma Limited. The label includes dosage instructions, storage conditions, and distributor information, listing 50 tablets per package. The label states the tablets contain Levofloxacin USP 500 mg and are made in India.*
FDA Label Image

Package Label-principal Display Panel (500 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (500 mg Blister Carton (10 x 10 Unit-dose))
Packaging label for Levofloxacin Tablets USP 500 mg by Aurobindo Pharma Limited. The label indicates a unit-dose tablet form with 100 tablets (10 x 10) in unit-dose packaging. It includes storage instructions, dispensing guidelines, and cautions, with the labeler address listed as Aurobindo Pharma USA, Inc., East Windsor, NJ.*
FDA Label Image

Package Label-principal Display Panel (750 mg (20 Tablet Bottle))

Package Label-principal Display Panel (750 mg (20 Tablet Bottle))
Label for Once-a-day Levofloxacin Tablets USP 750 mg, film-coated tablets for further processing, distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, dispensing guidelines, barcode, and a note for pharmacists to provide a medication guide with each patient supply. The package size indicated is 20 tablets.*
FDA Label Image

Package Label-principal Display Panel (750 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (750 mg Blister Carton (10 x 10 Unit-dose))
Packaging label for Levofloxacin Tablets USP 750 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates prescription use, one-a-day dosage, and a unit-dose count of 100 tablets (10 x 10). It includes storage instructions, pharmacist dispensing guidance, and the distributor information for Aurobindo Pharma USA, Inc.*
FDA Label Image

Chemical Structure (Levofloxacin Str)

Chemical Structure (Levofloxacin Str)
Chemical structure of levofloxacin showing its molecular formula including a fluorine atom, carboxylic acid group, piperazine ring, and additional functional groups, with a hydrate notation (1/2 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.